Company Dyadic International, Inc. Other OTC
Equities
US26745T1016
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Industrial Enzymes and Other Proteins
100.0
%
| 3 | 100.0 % | 3 | 100.0 % | -1.07% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States and Netherlands
100.0
%
| 3 | 100.0 % | 3 | 100.0 % | -1.07% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Mark Emalfarb
FOU | Founder | 69 | 01/79/01 |
Ping Rawson
DFI | Director of Finance/CFO | 48 | 01/16/01 |
Joseph Hazelton
COO | Chief Operating Officer | 48 | 09/21/09 |
Ronen Tchelet
CTO | Chief Tech/Sci/R&D Officer | 66 | 06/14/06 |
Doug Pace
PRN | Corporate Officer/Principal | - | 09/23/09 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Emalfarb
FOU | Founder | 69 | 01/79/01 |
Jack Kaye
BRD | Director/Board Member | 80 | 01/15/01 |
Michael Tarnok
BRD | Director/Board Member | 69 | 12/14/12 |
Patrick Lucy
CHM | Chairman | 56 | 08/21/08 |
Seth Herbst
BRD | Director/Board Member | 66 | 20/08/20 |
Barry Buckland
BRD | Director/Board Member | 76 | 03/18/03 |
Arindam Bose
BRD | Director/Board Member | 71 | 15/16/15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 41,490,316 | 20,348,574 ( 49.04 %) | 12,253,502 ( 29.53 %) | 49.04 % |
Company contact information
Dyadic International, Inc.
1044 North US Highway One Suite 201
33477-5094, Jupiter
+
http://www.dyadic.comSector
1st Jan change | Capi. | |
---|---|---|
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+47.13% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |